Gossamer Bio (GOSS) Reports Q3 Loss, Tops Revenue Estimates

Gossamer Bio (GOSS) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus Estimate of a loss of$ 0.18. This compares to loss of $0.21 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 22.22%. A quarter ago, it was expected that this biopharmaceutical company would post earnings of$ 0.23 per share when it actually produced earnings of $0.22, delivering a surprise of -4.35%.Over the last four quarters, the c ...